The synthetic cartilage application by Cartiva Inc., may be on its way to making history thanks to a final vote of 8-2 with two abstentions that the benefits of the device outweigh the risks, although the FDA advisory panel recommended a hefty post-approval study.

Johnson & Johnson(J&J) reported a strong first quarter overall, beating quarterly earnings forecasts on prescription drug revenue, but the company's medical device business has seen better days.